Bing-zhou Xue
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression.
Journal: Cell death & disease
Published: May 18, 2026
Correction to: CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells.
Journal: Stem cell research & therapy
Published: September 07, 2021
Cell fusion in cancer hallmarks: Current research status and future indications.
Journal: Oncology letters
Published: December 05, 2020
CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells.
Journal: Stem cell research & therapy
Published: September 17, 2020
Roles of long non-coding RNAs in the hallmarks of glioma.
Journal: Oncology letters
Published: October 25, 2019
Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
Journal: Stem cell research & therapy
Published: August 26, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026